Skip to main content
SpringerLink
Log in

In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistantStaphylococcus aureus

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The in vitro activity of meropenem, a carbapenem antibiotic, combined with eight other β-lactams against methicillin-resistantStaphylococcus aureus (MRSA) was tested. The MICs of these antibiotics alone ranged from 12.5 to 1,600 µg/ml for the 25 clinical isolates of MRSA studied. All combinations with meropenem exhibited marked synergy as determined by the checkerboard method. The MICs in combinations of meropenem with other β-lactams were reduced to 1/4 – 1/64 those of the antibiotics alone. No antagonism was observed for any of the combinations of meropenem with other β-lactams. Synergism between meropenem and cefpiramide was the highest among the combinations tested, the geometric mean of the fractional inhibitory concentration index for this combination being 0.237. This combination also demonstrated strong bactericidal activity, the MBCs decreasing to 1/16 – 1/64 of those for the agents alone. In terms of the fractional inhibitory concentration index, this was the most effective combination against MRSA highly resistant to meropenem alone with synergism for 85 % (81/95) of the strains. In addition, synergism of imipenem with cephalosporins against MRSA was demonstrated. The affinity of meropenem and cefpiramide for MRSA penicillin-binding protein (PBP) 2′ was very low, and the combination of both antibiotics showed an additive increase in affinity for this protein, but not a synergistic increase. Thus, the mechanism of synergism did not seem to be related to affinity for PBP2′. It is possible that there is another factor besides PBP2′ which increases the resistance of MRSA and that the combinations inhibit the unknown factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barber M Methicillin-resistant staphylococci. Journal of Clinical Pathology 1961, 14: 385–393.

    Google Scholar 

  2. Dowling HF The newer penicillins. Clinical Pharmacology and Therapeutics 1961, 2: 572–580.

    Google Scholar 

  3. Jevons MP “Celbenin” -resistant staphylococci. British Medical Journal 1961, i: 124–125.

    Google Scholar 

  4. Deguchi K Sensitivity ofStaphylococcus aureus isolated clinically to CEPs. Japanese Journal of Antibiotics 1982, 35: 807–811.

    Google Scholar 

  5. Wenzel RP The emergence of methicillin-resistantStaphylococcus aureus. Annals of Internal Medicine 1982, 97: 440–442.

    Google Scholar 

  6. Acar JF, Courvalin P, Chabbert YA Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins. Antimicrobial Agents and Chemotherapy 1970, 10: 280–285.

    Google Scholar 

  7. Cafferke MT, Hone R, Keane CT Antimicrobial chemotherapy of septicemia due to methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1985, 28: 819–823.

    Google Scholar 

  8. Peacock JE, Moorman DR, Wenzel RP, Mandell GL Methicillin-resistantStaphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. Journal of Infectious Diseases 1981, 144: 575–582.

    Google Scholar 

  9. Schaefler S Methicillin-resistant strains ofStaphylococcus aureus resistant to quinolones. Journal of Clinical Microbiology 1989, 27: 335–336.

    Google Scholar 

  10. Alvarez S, Jones M, Berk SL In vitro activity of fosfomycin, alone and in combination, against methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1985, 28: 689–690.

    Google Scholar 

  11. Varaldo PE, Debbia E, Schito GC In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species. Antimicrobial Agents and Chemotherapy 1985, 27: 615–618.

    Google Scholar 

  12. Blumberg PM, Strominger JL Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes. Bacteriological Reviews 1974, 38: 291–335.

    Google Scholar 

  13. Spratt BG Biological and genetical approaches to the mechanism of action of penicillin. Philosophical Transactions of the Royal Society of London, 1980, B 289: 273–283.

    Google Scholar 

  14. Suginaka H, Blumberg PM, Strominger JL Multiple penicillin-binding components inBacillus subtilis, Bacillus cereus, Staphylococcus aureus, andEscherichia coli. Journal of Biological Chemistry 1972, 247: 5279–5288.

    Google Scholar 

  15. Kozarich JW, Sambrook J A membrane enzyme fromStaphylococcus aureus which catalyzes transpeptidase, carboxypeptidase, and penicillinase activities. Journal of Biological Chemistry 1978, 253: 1272–1278.

    Google Scholar 

  16. Wyke AW, Ward JB, Hayes MV, Curtis NAC A role in vivo for penicillin-binding protein-4 ofStaphylococcus aureus. European Journal of Biochemistry 1981, 119: 389–393.

    Google Scholar 

  17. Ubukata K, Yamashita N, Konno M Occurrence of a β-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy 1985, 27: 851–857.

    Google Scholar 

  18. Utsui Y, Yokota T Role of an altered penicillin-binding protein in methicillin- and cephem-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1985, 28: 397–403.

    Google Scholar 

  19. Hartman BJ, Tomasz A Low-affinity penicillin-binding protein associated with β-lactam resistance inStaphylococcus aureus. Journal of Bacteriology 1984, 158: 513–516.

    Google Scholar 

  20. Reynolds PE, Fuller C Methicillin-resistant strains ofStaphycococcus aureus; presence of identical additional penicillin-binding protein in all strains examined. FEMS Microbiology Letters 1986, 33: 251–254.

    Google Scholar 

  21. Brown DFJ, Reynolds PE Intrinsic resistance to β-lactam antibiotics inStaphylococcus aureus. FEBS Letters 1984, 122: 275–278.

    Google Scholar 

  22. Reynolds PE, Brown DFJ Penicillin-binding proteins of β-lactam-resistant strains ofStaphylococcus aureus: effect of growth conditions. FEBS Letters 1985, 192: 28–32.

    Google Scholar 

  23. Neu HC, Novelli A, Chin NX In vitro activity and β-lactamase stability of a new carbapenem, SM-7338. Antimicrobial Agents and Chemotherapy 1989, 33: 1009–1018.

    Google Scholar 

  24. Sumita Y, Inoue M, Mitsuhashi S In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 908–916.

    Google Scholar 

  25. O'Callaghan CH, Morris A, Kirby SM, Shingler AH Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1972, 1: 283–288.

    Google Scholar 

  26. Waley SG A spectrophotometric assay of β-lactamase action on penicillins. Biochemical Journal 1974, 139: 780–789.

    Google Scholar 

  27. Spratt BG Properties of the penicillin-binding proteins ofEscherichia coli K12. European Journal of Biochemistry 1977, 72: 341–352.

    Google Scholar 

  28. Sumita Y, Fukasawa M, Okuda T Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins inStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1990, 34: 484–486.

    Google Scholar 

  29. Carvajal A In vitro activity and synergism of fosfomycin and cefotaxime. Journal of Antimicrobial Chemotherapy 1985, 16: 677.

    Google Scholar 

  30. Courcol RJ, Martin GR In vitro activity of the combination of ceftriaxone and fosfomycin against staphylococci. Journal of Antimicrobial Chemotherapy 1987, 19: 276–278.

    Google Scholar 

  31. Chin NX, Neu MN, Neu HC Synergy of fosfomycin with β-lactam antibiotics against staphylococci and aerobic gram-negative bacilli. Drugs under Experimental and Clinical Research 1986, 12: 943–947.

    Google Scholar 

  32. Utsui Y, Ohya S, Magaribuchi T, Tajima M, Yokota T Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin-and cephem-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1986, 30: 917–922.

    Google Scholar 

  33. Kobayashi S, Arai S, Hayashi S, Sakaguchi T In vitro effects of β-lactams combined with β-lactamase inhibitors against methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1989, 33: 331–335.

    Google Scholar 

  34. Hartman BJ, Tomasz A Expression of methicillin resistance in heterogeneous strains ofStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1986, 29: 85–92.

    Google Scholar 

  35. Chambers HF, Hackbarth CJ Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance inStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1987, 31: 1982–1988.

    Google Scholar 

  36. Murakami K, Nomura K, Doi M, Yoshida T Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1987, 31: 1307–1311.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Episome Institute, 2220, Kogure, Fujimi-mura, Seta-gun, 371-01, Gunma, Japan

    Y. Sumita & S. Mitsuhashi

  2. Research Laboratories, Sumitomo Pharmaceuticals Co., Ltd., 3-1-98, Kasugade-naka, Konohana-ku, 554, Osaka, Japan

    Y. Sumita

Authors
  1. Y. Sumita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Mitsuhashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sumita, Y., Mitsuhashi, S. In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistantStaphylococcus aureus . Eur. J. Clin. Microbiol. Infect. Dis. 10, 77–84 (1991). https://doi.org/10.1007/BF01964412

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964412

Keywords

Search

Navigation